Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 29, 2017 - Issue 10
Submit an article Journal homepage
504
Views
14
CrossRef citations to date
0
Altmetric
Articles

Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3–5 years of age, exposed pre- and perinatally to anti-retroviral medications

Mary Lou SmithDepartment of Psychology, University of Toronto Mississauga, Mississauga, ON, Canada;Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada;Neurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, Toronto, ON, CanadaCorrespondence[email protected]
View further author information
,
Klajdi PukaDepartment of Psychology, The Hospital for Sick Children, Toronto, ON, CanadaView further author information
,
Ramandeep SehraDepartment of Psychology, The Hospital for Sick Children, Toronto, ON, CanadaView further author information
,
Stanley E. ReadDivision of Infectious Diseases, The Hospital for Sick Children, Toronto, ON, CanadaView further author information
&
Ari BitnunDivision of Infectious Diseases, The Hospital for Sick Children, Toronto, ON, CanadaView further author information
Pages 1302-1308 | Received 09 Sep 2016, Accepted 26 Apr 2017, Published online: 08 May 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Julia M. Young, Ari Bitnun, Stanley E. Read & Mary Lou Smith. (2021) Early academic achievement of HIV-exposed uninfected children compared to HIV-unexposed uninfected children at 5 years of age. Child Neuropsychology 27:4, pages 532-547.
Read now
P. E. Springer, A. L. Slogrove, M. Kidd, E. Kalk, J. A. Bettinger, M. M. Esser, M. F. Cotton, M. Zunza, C. D. Molteno & M. Kruger. (2020) Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2–3 years of age in Cape Town, South Africa. AIDS Care 32:4, pages 411-419.
Read now

Articles from other publishers (12)

Mary Glenn Fowler, Colleen Hanrahan, Nonhlanhla Yende, Lynda Stranix-Chibanda, Tsungai Chipato, Limbika Maliwichi, Luis Gadama, Jim Aizire, Sufia Dadabhai, Lameck Chinula, Lillian Wambuzi-Owang, Maxensia Owor, Avy Violari, Mandisa Nyati, Sherika Hanley, Vani Govender, Sean Brummel & Taha Taha. (2022) Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3–6 years. AIDS 36:11, pages 1533-1543.
Crossref
Catherine J Wedderburn, Ella Weldon, Cesc Bertran-Cobo, Andrea M Rehman, Dan J Stein, Diana M Gibb, Shunmay Yeung, Andrew J Prendergast & Kirsten A Donald. (2022) Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis. The Lancet Child & Adolescent Health 6:6, pages 393-408.
Crossref
Wenqiang Fan, Kimberly M. Christian, Hongjun Song & Guo-li Ming. (2022) Applications of Brain Organoids for Infectious Diseases. Journal of Molecular Biology 434:3, pages 167243.
Crossref
AE Ezeamama, SK Zalwango, A Sikorskii, R Tuke, PM Musoke, B Giordani & MJ Boivin. (2021) In utero and peripartum antiretroviral exposure as predictor of cognition in 6‐ to 10‐year‐old HIV‐exposed Ugandan children – a prospective cohort study . HIV Medicine 22:7, pages 592-604.
Crossref
Jordan G. Schnoll, Brian Temsamrit, Daniel Zhang, Hongjun Song, Guo-li Ming & Kimberly M. Christian. (2019) Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches. Journal of Neuroimmune Pharmacology 16:1, pages 113-129.
Crossref
Nicolas Nagot, Mandisa Singata-Madliki, Amandine Cournil, Joyce Nalugya, Souleymane Tassembedo, Catherine Quillet, Melany W. Tonga, James Tumwine, Nicolas Meda, Chipepo Kankasa, Mwiya Mwiya, Paul Bangirana, Marianne Peries, Joanne Batting, Ingunn M. S. Engebretsen, Thorkild Tylleskär, Philippe Vande Perre, Grace Ndeezi & Jean-Pierre Molès. (2021) Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life. Scientific Reports 11:1.
Crossref
Julian C. Gilmore, Lena Serghides & Reina Bendayan. (2021) Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected. AIDS 35:1, pages 1-14.
Crossref
Ambalika Sarkar, Kayode Balogun, Monica S. Guzman Lenis, Sebastian Acosta, Howard T. Mount & Lena Serghides. (2020) In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PLOS ONE 15:11, pages e0242513.
Crossref
Micah Piske, Matthew A. Budd, Annie Q. Qiu, Evelyn J. Maan, Laura J. Sauvé, John C. Forbes, Ariane Alimenti, Patricia Janssen & Hélène C.F. Côté. (2018) Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children. AIDS 32:17, pages 2583-2592.
Crossref
Stanzi M. le Roux, Kirsten A. Donald, Kirsty Brittain, Tamsin K. Phillips, Allison Zerbe, Kelly K. Nguyen, Andrea Strandvik, Max Kroon, Elaine J. Abrams & Landon Myer. (2018) Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa. AIDS 32:13, pages 1781-1791.
Crossref
Elaine J. Abrams, Jintanat Ananworanich, Moherndran Archary, McNeil Ngongondo & Pim Brouwers. (2018) Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration. JAIDS Journal of Acquired Immune Deficiency Syndromes 78:1, pages S32-S39.
Crossref
Frances C. Robertson, Martha J. Holmes, Mark F. Cotton, Els Dobbels, Francesca Little, Barbara Laughton, André J. W. van der Kouwe & Ernesta M. Meintjes. (2018) Perinatal HIV Infection or Exposure Is Associated With Low N-Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years. Frontiers in Human Neuroscience 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.